Personal Health Record Software for Neuroendocrine Tumors: Patient-Centered Design Approach
Authors:
- Juan Pablo HourcadeJuan Pablo Hourcade
- Michael O'ROrkeMichael O'ROrke
- Elizabeth ChrischillesElizabeth Chrischilles
- Nicholas J RudzianskiNicholas J Rudzianski
- Brian GryzlakBrian Gryzlak
- Kerry PetermanKerry Peterman
- Chris OrtmanChris Ortman
- Sam WolstencroftSam Wolstencroft
- Margaret BeanMargaret Bean
- Elyse GellermanElyse Gellerman
- Josh A MailmanJosh A Mailman
- Maryann WahmannMaryann Wahmann
Open Access
- 3 June 2025
- journal article
- Published by JMIR Publications Inc. in JMIR Human Factors
- Vol. 12 (1) , e68788
Abstract
Background: Personal health record (PHR) software has the potential of aiding with patient engagement and data collection in longitudinal research to better understand the long-term impact of treatments on patients with rare medical conditions. Neuroendocrine tumors (NETs) represent a rare condition with unique challenges related to symptom management, treatment tracking, and patient-provider communication. Objective: This study aimed to design, develop, and evaluate PHR software tailored for patients with NETs as part of a longitudinal research study. Our goal was to create a patient-centered PHR that supports both self-management and research data collection. Methods: This included activities spanning the entire development lifecycle from identifying user requirements through focus groups and surveys, iterative prototype refinement via cognitive walkthroughs, and usability testing of the functional PHR system. Feedback from patient advocacy organizations and clinical experts further informed PHR development. Results: The resulting PHR allows patients with NETs to access condition-specific information, track symptoms, monitor treatment regimens, and share data with health care providers. Patients valued the ability to visualize personal health trends and patterns over time, enhancing both self-management and communication with medical teams. Usability testing indicated high levels of patient satisfaction with the system’s functionality and design. Conclusions: The development of this PHR demonstrates the value of engaging patients in the design process to ensure that health technologies address real-world needs. Our approach provides a model for designing PHR systems for other rare conditions, highlighting the importance of patient-centered design in supporting both clinical care and longitudinal research.Keywords
This publication has 44 references indexed in Scilit:
- Pulmonary neuroendocrine (carcinoid) tumors: European Neuroendocrine Tumor Society expert consensus and recommendations for best practice for typical and atypical pulmonary carcinoidsAnnals of Oncology, 2015
- Personal health records: a randomized trial of effects on elder medication safetyJournal of the American Medical Informatics Association, 2013
- Factors affecting usage of a personal health record (PHR) to manage health.Psychology and Aging, 2013
- The joint IAEA, EANM, and SNMMI practical guidance on peptide receptor radionuclide therapy (PRRNT) in neuroendocrine tumoursEuropean Journal of Nuclear Medicine and Molecular Imaging, 2013
- Evaluation of a prototype electronic personal health record for patients with idiopathic thrombocytopenic purpuraPatient Preference and Adherence, 2012
- Neuroendocrine TumorsJournal of the National Comprehensive Cancer Network, 2012
- Willingness to share personal health record data for care improvement and public health: a survey of experienced personal health record usersBMC Medical Informatics and Decision Making, 2012
- Use of Electronic Health Records in U.S. HospitalsNew England Journal of Medicine, 2009
- Clinical research for rare disease: Opportunities, challenges, and solutionsMolecular Genetics and Metabolism, 2009
- Rare diseases and orphan drugsBritish Journal of Clinical Pharmacology, 2006